The reduction of myocardial beta-adrenoceptor density in congestive heart failure has been thought to be caused by agonistinduced homologous desensitization. However, recent evidence suggests that excessive adrenergic stimulation may not produce myocardial beta-receptor downregulation unless there is an additional defect in the local norepinephrine (NE) uptake mechanism. To investigate the association between betaadrenoceptor regulation and NE uptake activity, we carried out studies in 30 dogs with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary artery constriction and 23 sham-operated control dogs. We determined NE uptake activity by measuring accumulation of IHINE in tissue slices, NE uptake-i carrier density by V3Hlmazindol binding and beta-adrenoceptor density by VHJdihydroalprenolol binding. Compared with sham-operated dogs, RHF dogs showed a 26% decrease in beta-adrenoceptor density, a 51% reduction in NE uptake activity, and a 57% decrease in NE uptake-i carrier density in their right ventricles. In addition, right ventricle beta-receptor density correlated significantly with NE uptake activity and NE uptake-i carrier density. In contrast, neither NE uptake activity nor beta-receptor density in the left ventricle and renal cortex was affected by RHF. Thus, the failing myocardium is associated with an organ-and chamber-specific subnormal neuronal NE uptake. This chamber-specific loss of NE uptake-i carrier could effectively reduce local NE clearance, and represent a local factor that predisposes the failing ventricle to beta-adrenoceptor downregulation.
Introduction
Human congestive heart failure is associated with an increase in circulating norepinephrine (1) (2) (3) (4) , increase in myocardial release ofcatecholamines (5), beta-adrenergic subsensitivity (2, Receivedfor publication 15 June 1988 and in revisedform 1 May 1989. 6, 7), and a reduced number of myocardial beta-adrenergic receptors (6, 7) . Since the number ofcell surface beta-receptors decreases in a variety ofin vitro cell preparations after beta-agonist exposure (8) (9) (10) , the reduction in myocardial beta-receptor number in heart failure has been thought to be caused by agonist-induced downregulation, known also as homologous desensitization (8) . However, chronic intravenous administration of NE in intact dogs has failed to decrease myocardial beta-receptor number (11, 12) . Nevertheless, these findings do not refute the role of homologous desensitization since plasma NE concentration is not necessarily similar to the neurotransmitter concentration at the synaptic cleft. The synaptic NE surrounding beta-receptors is influenced not only by the circulating NE, but also by the amount of neuronally released NE, local metabolizing enzymes, and adequacy of NE uptake activity at the presynaptic nerve endings. Because neuronal reuptake is the major mechanism in terminating the pharmacological action of catecholamines, we speculate that unless the NE uptake mechanism is defective, NE infusion may not increase synaptic NE concentration sufficiently high to cause beta-receptor downregulation. Indeed, unlike the response in intact normal dogs, NE infusion causes a decrease in myocardial beta-receptor density in dogs after cardiac denervation (13) , a condition that has been shown to reduce NE uptake (14) . Increasing evidence has accumulated that myocardial NE uptake activity is depressed in failing myocardium (15) (16) (17) . In this study we sought to determine whether the reduction of myocardial beta-adrenoceptor density in heart failure is associated with alterations in NE uptake activity. Studies were performed in dogs with experimental right heart failure (RHF)' produced by tricuspid avulsion and progressive pulmonary artery constriction. As in patients with heart failure caused by primary pulmonary hypertension (18) , such animals exhibit a chamber-specific reduction of myocardial betaadrenoceptors in the failing right ventricle, while the left ventricular beta-receptor number remains normal (19) . Since both the right and left ventricles are exposed to the same levels of circulating NE, this animal preparation offers a unique opportunity to determine whether a local factor in the right ventricle accounts for the chamber-specific beta-receptor downregulation. We measured beta-adrenoceptor density, NE uptake activity, and NE uptake-I carrier density in both the right and left ventricles. The left kidney was studied as an extracardiac reference. Results of the study indicate that the beta-adrenoceptor downregulation in RHF is associated with a chamberand organ-specific reduction in NE uptake-l carrier density and decrease in NE uptake activity. filter paper, and placed in 4 ml of a modified Krebs solution containing 100 MAM pargyline. 10 min later, with the tissue freely suspended, 50 ,ul ofa tyramine solution was added into the incubation medium to achieve a final concentration of 100,M. Beginning with the addition oftyramine, 50-Ml aliquots ofthe incubation medium were taken for counting 3H-radioactivity at 5-min intervals for 25 min. Finally, 200 IAl ofa 75% TCA solution was added to extract tissue NE; an aliquot ofthe incubation solution was taken for calculating the total amount of (3H]NE present in the tissue. Spontaneous release of 3H was determined by parallel incubation of two other tissue slices, using deionized water instead oftyramine. The difference in 3H release between the tissue slices with and without tyramine was taken to indicate the tyramine-induced release of NE.
Preparation of the ventricular and renal particulate fractions. A block of ventricular free wall was trimmed free offat, large vessels, and 1 mm of its inner and outer surfaces. It was minced and homogenized in an ice-cold 50 mM Tris HCI buffer (buffer I, pH 7.7 at 25°C), using a PCU-2 homogenizer (8-s burst X 5 at setting 8). The homogenate was diluted with additional Tris buffer and centrifuged at 500 g for 15 min at 4°C. The supernatant were spun again at 40,000 gfor 15 min at 4°C. The resulting pellets were resuspended and washed with a second buffer solution containing 50 mM Tris HCI, 120 mM NaCI, 5 mM KCI, pH 7.4 at 250C (buffer II), and filtered through a 53-Am nylon mesh. This filtrate containing crude membrane fractions was then diluted with buffer II to yield a protein concentration of -0.35 mg/ml for radioligand binding studies. Protein concentration was determined in triplicate by the method of Lowry et al. (25) , using bovine serum albumin as a standard.
The renal cortex was trimmed free of capsular membranes and large vessels, minced with scissors, and homogenized in ice-cold buffer I using a Polytron homogenizer (8-s burst X 3 at setting 6). The homogenate was centrifuged at 500 g for 15 min at 4°C. The supernatant was spun again at 40,000 g for 15 min at 4°C. The resultant pellet was resuspended in buffer I Data analysis. Results are expressed as mean±SE. The statistical significance of differences between the RHF and sham-operated dogs was determined using analysis of variance for determining equality of variance and t test for unpaired data. The degree of relatedness between two variables was determined using Pearson's correlation coefficient and coefficient of determination. The data were analyzed using RS/ I data analysis system (BBN Software Products Corp., Cambridge, MA). Values were considered statistically significant if P < 0.05.
Results
Resting systemic hemodynamics. Animals with RHF showed prominent ascites and a heavier body weight than sham-operated controls (Table I ). The RHF animals also had a signifi- Plasma and tissue catecholamine levels. Arterial plasma NE and epinephrine concentrations were elevated in RHF (Table II) . In contrast, myocardial NE content was markedly reduced. Furthermore, although NE was reduced in both ventricles, NE depletion was significantly greater in the failing right ventricle than in the left ventricle. In contrast, renal NE content did not differ between the RHF and sham-operated dogs.
Beta-adrenoceptor density. Table III shows that compared with sham-operated dogs, RHF dogs had a 26% decrease in right ventricular beta-adrenoceptor density. In contrast, neither left ventricular nor renal beta-adrenoceptor density differed between the two groups. Nor did the two groups differ in their dissociation constants of the beta-adrenoceptors in the right ventricle and kidneys. However, the dissociation constant of the left ventricular beta-adrenoceptor was slightly greater in RHF dogs than sham-operated dogs.
NE uptake activity and binding sites. Specific 3H uptake activity was measured to approximate NE uptake activity. Fig.  1 Fig. 3 shows the cumulative relative release of 3H over a 25-min period from the right and left ventricular muscle slices in the presence and absence of tyramine. Neither the spontaneous release nor tyramine-induced release of 3H differed significantly in the right or left ventricle between the RHF and sham animals.
Correlation of beta-adrenoceptor density with NE uptake and plasma NE. Table VI lists correlation coefficients and coefficients of determination for correlations between betaadrenoceptor density and biochemical measurements in the failing right ventricle. Beta-receptor density correlated significantly with both NE uptake activity (Fig. 4) and NE uptake-I carrier density. NE uptake activity also correlated significantly with NE uptake-l carrier density (Fig. 5 ). In addition, there was an inverse correlation between beta-receptor density and NE content of the failing hearts. In contrast, right ventricular Values are mean±SE. The number of experiments is given in parentheses. * P < 0.0001 compared with the sham group. beta-receptor density correlated with neither plasma NE concentration nor the duration of heart failure in the RHF dogs. Because the precise timing of onset of RHF could not be defined, the duration of RHF was approximated by the interval between the second surgery and sacrifice (35- duced in the failing right ventricle, but is relatively unchanged in the left ventricle. Similar chamber-specific changes have been reported in patients with right ventricular failure secondary to primary pulmonary hypertension (18) . The RHF dogs have been extensively studied; they exhibit an increase in plasma catecholamines, a decrease in myocardial NE stores, a reduced responsiveness to beta-receptor agonists (19), and other neurohormonal and reflex changes (30) (31) (32) (33) (34) that occur in patients with congestive heart failure. Specific 3H uptake activity, defined as the difference in radioactivity between tissue slices incubated in a [3H]NE-containing solution at 370C (total 3H uptake) and those at 40C (nonspecific 3H uptake), was taken to approximate NE uptake activity in the present study. Ascorbic acid and nialamide were Discussion As we have shown previously in dogs with RHF (19), our present study confirms that beta-adrenoceptor number is re- added to our incubation medium to retard spontaneous oxidation of NE and the activity of monoamine oxidase. Sharma and Banerjee (24) have shown that under the same experimental conditions, > 90% of the tissue radioactivity derives from the unmetabolized catecholamine. These findings are consistent with the observation that NE metabolites account for < 4% ofthe total 3H recovered in a similar incubation medium (35) . Furthermore, as shown by Sharma and Banerjee (24) , we have confirmed that the temperature-dependent accumulation of 3H in heart muscle can be either abolished or markedly reduced by ouabain, a Na+-K+ ATPase inhibitor, and desipramine, a NE uptake-1 carrier inhibitor (unpublished data). On the other hand, propranolol, phentolamine, and prazocin exert no effects on specific 3H uptake. These findings indicate that the specific 3H uptake is an active, energy-dependent process that requires normally functioning NE uptake-1 carrier sites, and that binding of [3H]NE to alpha-and beta-adrenoceptors contributes negligibly to the total tissue 3H radioactivity. Our present study indicates no difference in either spontaneous or tyramine-induced release of NE between the normal and failing right ventricles. Similarly, using an in vivo labeling technique, Spann et al. (36) found the absolute levels of specific activity and the rates of disappearance were identical in the left ventricles of normal guinea pigs and those with heart failure produced by aortic constriction. The relative net turnover rates of NE were the same in the normal and failing hearts. The investigators concluded that NE release was not increased in heart failure. These results suggest that the primary defect of NE metabolism of the failing ventricle lies in the NE uptake mechanism.
Compared with sham animals, RHF dogs showed an average of 51% reduction ofNE uptake activity and a 26% decrease in beta-receptor number in the failing right ventricle. Like that of beta-receptor number, this change in NE uptake was not only organ specific but also chamber specific, because neither the left ventricle nor the kidney showed abnormal NE uptake activity. Our [3H]mazindol binding data further indicate that the diminished NE uptake activity was associated, at least in part, with a reduction in the number of NE uptake-1 carrier.
Our results further show that myocardial beta-receptor number correlated significantly with NE uptake activity and NE uptake-1 carrier density in the failing heart. Although the associations do not establish a cause and effect relationship, the coefficient of determination indicates that NE uptake activity contributed statistically to 66.8% of the changes in total beta-receptor number in the study. Recent evidence indicates that the decrease in beta-receptor number in the failing human heart is caused predominantly by a selective downregulation of beta-1 receptors (37). Unlike beta-1 receptors, myocardial beta-2 receptors do not change significantly in heart failure. If the human findings could be extrapolated to the experimental animals, the reduction of total beta-receptor number in our animals probably also was due to a selective decrease in beta-1 receptors. The percent decrease of beta-1 receptor density would then be expected to be greater than that oftotal beta-receptor density, and the beta-1 receptor number might be more closely correlated with NE uptake activity than was the total beta-receptor number. However, because we employed the nonselective antagonist alprenolol, our present study does not allow us to discriminate between the beta-receptor subtypes. Further investigations might be needed to establish the quantitative correlation between NE uptake activity and beta-1 receptor number.
The mechanism by which NE uptake-I carrier density was reduced is not known. However, it cannot be explained by an increase in muscle mass alone, because right ventricular weight increased only 26%. NE uptake-I carrier sites may decrease in number either because of loss of adrenergic nerve fibers in the failing myocardium or because of a specific mechanism of NE uptake-I carrier downregulation. It is not known whether the number of NE uptake-1 carrier sites can be regulated by concentrations of either synaptic NE or other neurotransmitters.
Decrease in tissue NE uptake alone probably is inadequate to increase synaptic NE and cause beta-receptor downregulation. Studies have shown that in hearts devoid of NE uptake function such as occurs after either surgical or pharmacological denervation (13) , myocardial beta-receptor number either shows no changes (38) or actually increases (39, 40) .
Increased circulating NE is an index of heightened sympathetic tone, and has often been implicated to be the cause of beta-adrenergic subsensitivity and beta-adrenoceptor downregulation in congestive heart failure. However, circulating NE is not a precise measure of adrenergic synaptic NE directly surrounding beta-receptors. In tissues with a competent adrenergic neuronal uptake system, synaptic NE is taken up avidly by nerve endings and, even in the presence of excessive sympathetic stimulation, may not increase to a level sufficiently high to reduce beta-receptor number. In vitro studies have shown that beta-receptor downregulation by agonists occurs in a concentration-dependent, and time-dependent fashion (41, 42) . The initial reaction after exposure to beta-agonists involves an uncoupling ofbeta-receptors from adenylate cyclase; reduction of cell surface beta-receptor number occurs later and only if a critically high agonist level is reached. In contrast, synaptic NE is expected to increase markedly after sympathetic stimulation in tissues with suppressed NE uptake. In our present study despite an increase in circulating NE levels, beta-receptor number was reduced only in the right ventricle, where a subnormal NE uptake activity was also documented. Neither the left ventricle nor the kidneys showed a depressed NE uptake activity or a reduction of beta-receptor number in RHF. This hypothesis is also consistent with the findings that myocardial beta-receptor number does not decrease after chronic intravenous administration of NE in normal dogs (1 1, 12) .
Our study shows no significant correlation between right ventricular beta-receptor number and arterial NE concentration in RHF dogs. Likewise, Limas et al. (43) found no significant correlation between arterial NE and myocardial beta-receptor number in patients with moderate to severe congestive heart failure. The latter investigators, however, noted that the two variables correlated significantly in patients with mild to moderate heart failure. The relationship between plasma NE and myocardial beta-receptor number was also studied in patients with dilated cardiomyopathy (44) . There was a weak correlation (r = -0.42) between arterial NE and myocardial beta-receptor number, but a tighter correlation (r = -0.64) existed between coronary sinus NE and myocardial beta-receptor, suggesting that changes of myocardial beta-receptor are causally related to cardiac-derived NE. Furthermore, using autoradiography, Murphree et al. (45) found that beta-receptor density was lower in the subendocardium than the subepicardium of tissue slices taken from patients with severe heart failure. This transmural gradation of beta-receptor density suggests that myocardial beta-receptor density is influenced by some local tissue factors. Further studies are warranted to determine whether NE uptake is more severely depressed, or whether interstitial NE is higher, in the subendocardial layer than the subepicardial layer.
NE was depleted in both the right and left ventricles of the RHF dogs. Similar results have been previously reported in human and experimental heart failure (46, 47) . This change appears to be specific to the heart, because NE concentration did not change significantly in the renal cortex. The decrease in myocardial NE probably is caused, at least in part, by the defective NE uptake mechanism (15, 36) . The lack of correlation between NE uptake activity and myocardial NE depletion in the left ventricles of RHF dogs in our present study, however, suggests that NE depletion cannot be accounted for by abnormal NE uptake alone. Alternatively, myocardial NE depletion could have resulted from decreased NE synthesis, as heart failure has been shown to be associated with a decrease in cardiac tyrosine hydroxylase activity (48) (49) (50) , or other ratelimiting steps for cardiac NE synthesis (51) .
The dissociation constant for [3H]DHA did not change significantly in either the right ventricle or renal cortex with the development of RHF. However, the dissociation constant of myocardial beta-receptors was slightly greater in the left ventricle ofthe RHF dog than the sham-operated control. The significance of this small increase in dissociation constant is not known. However, in dogs with left ventricular failure produced by aortic constriction, a much greater increase in dissociation constant has been noted (52) . An increase in dissociation constant also occurs after chronic administration of exogenous NE (12) , and probably is caused by loss of high-affinity beta-receptors (52, 53) .
Recently, the beta-receptor antagonist metoprolol has been found to increase lymphocyte and myocardial beta-receptor number in patients with congestive heart failure (54, 55), suggesting beta-receptor downregulation may be causally related to agonist stimulation. In addition, metoprolol therapy has been shown to improve patients' heart failure symptoms, exercise capacity, and left ventricular function (56, 57) . Most of these studies, however, were conducted in a small number of patients and were not placebo controlled. The question whether beta-receptor blockade in congestive heart failure reverses myocardial beta-receptor downregulation and increases myocardial inotropic responses to adrenergic stimulation deserves further extensive studies.
In summary, the present study indicates that right ventricular beta-receptor density correlated with the number oftissue NE uptake-l carrier sites. We also showed that the defect in NE uptake mechanism was found only in the failing right ventricle. This chamber-specific reduction of NE uptake carrier sites may be expected to increase synaptic NE concentration, particularly in the presence of excessive sympathetic stimulation, and to cause agonist-induced homologous desensitization. Our results further suggest that the lack of correlation between beta-receptor density and arterial NE concentration does not necessarily refute a role of agonist-induced homologous desensitization. Direct correlation between synaptic NE concentration and myocardial beta-receptor number is needed. Further experiments are warranted to determine whether the beta-receptor downregulation in heart failure is causally related to beta-agonist stimulation.
